Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.
Chiao-Ling LiMing-Chih HoYou-Yu LinSheng-Tai TzengYun-Ju ChenHsin-Yung PaiYa-Chun WangChi-Ling ChenYu-Hsin LeeDing-Shinn ChenShiou-Hwei YehPei-Jer ChenPublished in: Hepatology (Baltimore, Md.) (2020)
vh-DNA was shown to be a circulating biomarker for detecting the tumor load in majority of patients with HBV-related HCC and aided in monitoring residual tumor and recurrence clonality after tumor resection.